BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8403213)

  • 1. In vitro DNA damage and mutations induced by a macrocyclic tetraamide chromium(V) complex: implications for the role of Cr(V) peptide complexes in chromium-induced cancers.
    Dillon CT; Lay PA; Bonin AM; Dixon NE; Collins TJ; Kostka KL
    Carcinogenesis; 1993 Sep; 14(9):1875-80. PubMed ID: 8403213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disproportionation and nuclease activity of bis[2-ethyl-2-hydroxybutanoato(2-)]oxochromate(V) in neutral aqueous solutions.
    Levina A; Lay PA; Dixon NE
    Inorg Chem; 2000 Feb; 39(3):385-95. PubMed ID: 11229553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro plasmid DNA cleavage by chromium(V) and -(IV) 2-hydroxycarboxylato complexes.
    Levina A; Barr-David G; Codd R; Lay PA; Dixon NE; Hammershøi A; Hendry P
    Chem Res Toxicol; 1999 Apr; 12(4):371-81. PubMed ID: 10207127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromium(VI) reduction by catechol(amine)s results in DNA cleavage in vitro: relevance to chromium genotoxicity.
    Pattison DI; Davies MJ; Levina A; Dixon NE; Lay PA
    Chem Res Toxicol; 2001 May; 14(5):500-10. PubMed ID: 11368547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromium(V) complexes of hydroxamic acids: formation, structures, and reactivities.
    Gez S; Luxenhofer R; Levina A; Codd R; Lay PA
    Inorg Chem; 2005 Apr; 44(8):2934-43. PubMed ID: 15819581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxochromium(V) species formed with 2,3-dehydro-2-deoxy-N-acetylneuraminic or N-acetylneuraminic (sialic) acids: an in vitro model system of oxochromium(V) species potentially stabilized in the respiratory tract upon inhalation of carcinogenic chromium(VI) compounds.
    Codd R; Lay PA
    Chem Res Toxicol; 2003 Jul; 16(7):881-92. PubMed ID: 12870891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of a chromium(V) cis-dioxo bis(1,10-phenanthroline) complex and crystal and molecular structures of its chromium(III) precursor.
    Weeks CL; Levina A; Dillon CT; Turner P; Fenton RR; Lay PA
    Inorg Chem; 2004 Nov; 43(24):7844-56. PubMed ID: 15554650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and hydrogen peroxide-induced chromium(V) oxidation of deoxyribose in single-stranded and double-stranded calf thymus DNA.
    Sugden KD; Wetterhahn KE
    Chem Res Toxicol; 1997 Dec; 10(12):1397-406. PubMed ID: 9437531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of PM2 DNA breaks in the course of reduction of chromium(VI) by glutathione.
    Kortenkamp A; Ozolins Z; Beyersmann D; O'Brien P
    Mutat Res; 1989 Feb; 216(1):19-26. PubMed ID: 2918862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation and reactivity of chromium(V)-thiolato complexes: a model for the intracellular reactions of carcinogenic chromium(VI) with biological thiols.
    Levina A; Zhang L; Lay PA
    J Am Chem Soc; 2010 Jun; 132(25):8720-31. PubMed ID: 20527748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis of lymphocytes induced by chromium(VI/V) is through ROS-mediated activation of Src-family kinases and caspase-3.
    Vasant C; Rajaram R; Ramasami T
    Free Radic Biol Med; 2003 Nov; 35(9):1082-100. PubMed ID: 14572611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence for hydroxyl radical-induced damage to nucleic acids by chromium(VI)-derived species: implications for chromium carcinogenesis.
    Molyneux MJ; Davies MJ
    Carcinogenesis; 1995 Apr; 16(4):875-82. PubMed ID: 7537182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permeability, cytotoxicity, and genotoxicity of chromium (V) and chromium (VI) complexes in V79 Chinese hamster lung cells.
    Dillon CT; Lay PA; Bonin AM; Cholewa M; Legge GJ; Collins TJ; Kostka KL
    Chem Res Toxicol; 1998 Feb; 11(2):119-29. PubMed ID: 9511903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of modified cleavage termini from the reaction of chromium(V) with DNA.
    Sugden KD
    J Inorg Biochem; 1999; 77(3-4):177-83. PubMed ID: 10643657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
    Quievryn G; Peterson E; Messer J; Zhitkovich A
    Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, characterization, and nuclease activity of biologically relevant chromium(V) complexes with monosaccharides and model diols. Likely intermediates in chromium-induced cancers.
    Bartholomäus R; Irwin JA; Shi L; Smith SM; Levina A; Lay PA
    Inorg Chem; 2013 Apr; 52(8):4282-92. PubMed ID: 23531300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of chromium(VI) to chromium(V) by rat liver cytosolic and microsomal fractions: is DT-diaphorase involved?
    Aiyar J; De Flora S; Wetterhahn KE
    Carcinogenesis; 1992 Jul; 13(7):1159-66. PubMed ID: 1379126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electron paramagnetic resonance, kinetics of formation and decomposition studies of (bis(hydroxyethyl)amino-tris(hydroxymethyl)-methane)oxochromate(V): a model chromium(V) complex for DNA damage studies.
    Fonkeng BS; Moghaddas S; Bose RN
    J Inorg Biochem; 1998 Dec; 72(3-4):163-71. PubMed ID: 10065534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disproportionation of a model chromium(V) complex causes extensive chromium(III)-DNA binding in vitro.
    Levina A; Lay PA; Dixon NE
    Chem Res Toxicol; 2001 Aug; 14(8):946-50. PubMed ID: 11511167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediates produced in the reaction of chromium(VI) with dehydroascorbate cause single-strand breaks in plasmid DNA.
    Stearns DM; Wetterhahn KE
    Chem Res Toxicol; 1997 Mar; 10(3):271-8. PubMed ID: 9084906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.